Recent studies have revealed that MFSD12 (major facilitator superfamily domain containing 12) is overexpressed in various cancers and promotes cystine storage in lysosomes, which can effectively buffer GSH depletion and tumor cell damage, leading to chemotherapy resistance in patients with breast cancer [181]. This evidence concerns the gene MFSD12 and breast carcinoma.